What Happens When You Shoot Up Meth?

Injecting methamphetamine sends the drug into the bloodstream almost instantly, producing a surge of euphoria within seconds that is followed by a cascade of dangerous physiological effects across nearly every organ system. The drug reaches peak concentration in the blood within about five minutes and peak brain uptake within roughly ten minutes, which is part of why injection is the route most strongly associated with addiction and acute medical emergencies. What follows that initial rush ranges from cardiovascular strain and dangerously elevated body temperature to longer-term brain damage, psychosis, and a host of injection-related infections. The full picture is grimmer and more complex than the “high” alone would suggest.

The First Minutes After Injection

When methamphetamine enters a vein, it bypasses the digestive system entirely. Animal pharmacokinetic studies show the drug reaches peak blood concentration within about five minutes of administration, and it remains detectable in the blood for at least eight hours afterward.¹ In human brain-imaging research, methamphetamine’s uptake into the brain peaks around nine minutes after administration, with the drug distributing widely across cortical and subcortical regions as well as white matter. Critically, it clears the brain slowly, which helps explain why the behavioral effects last for hours even though the initial rush fades.²

That rapid brain entry is what produces the “rush” that people who inject meth describe. The drug forces a massive release of dopamine by hijacking the dopamine transporter, effectively running it in reverse so that dopamine floods the spaces between neurons instead of being recycled back inside them.³ The result is an intense feeling of energy, confidence, and pleasure that far exceeds anything the brain produces on its own. But the same mechanism that delivers the high also sets the stage for everything that goes wrong afterward.

What It Does to the Heart and Blood Vessels

Methamphetamine is a potent stimulant, and the cardiovascular system takes one of the hardest immediate hits. In studies of acute toxicity, people presenting to emergency departments after meth use commonly report anxiety, heart pounding, and rapid heart rate, with those symptoms appearing in roughly a third to nearly half of toxicity events.⁴ These are not just uncomfortable sensations. The drug drives blood pressure up sharply and can trigger vasospasm, where blood vessels suddenly constrict and cut off blood flow to tissue.

Over time, repeated injection accelerates cardiovascular disease in ways that normally take decades of aging or chronic illness. Research has documented increased rates of hypertension, left ventricular hypertrophy (the heart muscle thickening from overwork), and coronary artery disease in younger populations who use methamphetamine.⁵ Heart attack and stroke in people under 40 who use meth are not rare clinical occurrences. The drug essentially ages the cardiovascular system far beyond the person’s actual years.

How the Brain Gets Damaged

The dopamine flood that produces the high is itself toxic to neurons. When dopamine accumulates in abnormally large quantities outside the cell, it breaks down into reactive molecules that damage cell structures. This oxidative stress activates the brain’s immune cells, called microglia, which then release inflammatory signals that cause further neuronal injury. The process creates a destructive feedback loop: oxidative stress triggers inflammation, and inflammation amplifies the oxidative damage.⁶

The accumulated evidence from neurotoxicity research points to multiple pathways of brain damage, including disrupted dopamine and serotonin function, programmed cell death in neurons, and widespread neuroinflammation.⁷ Brain-imaging studies show methamphetamine distributes broadly across the brain, not just in the reward centers, which is consistent with the wide-ranging nature of the damage it causes: cognitive problems, emotional dysregulation, and motor issues can all result.²

That said, the picture of cognitive impairment is more nuanced than popular accounts suggest. A critical review of the literature found that while statistically significant differences between meth users and non-users do appear on some cognitive tests, the majority of cognitive performance scores still fall within the normal range when compared against standard norms.⁸ This does not mean the drug is safe for the brain. It means the “meth destroys your brain overnight” narrative oversimplifies things. Damage is real and cumulative, but many users retain more function than stereotypes would predict, especially if they stop using the drug.

Psychosis and Psychiatric Fallout

One of the most alarming consequences of chronic methamphetamine injection is psychosis. This is not a metaphor or exaggeration: meth-induced psychosis involves hallucinations, paranoid delusions, and disordered thinking that closely resemble schizophrenia. The symptoms can emerge during a binge and initially resolve when the drug wears off. But with repeated use, psychotic episodes become easier to trigger, last longer, and in some cases become permanent. Research shows that diagnoses of methamphetamine-induced psychosis frequently convert over time to a diagnosis of schizophrenia.⁹

The mechanism involves the same dopamine system that produces the high. The drug disrupts a protein called VMAT2 that normally packages dopamine safely inside cellular compartments. When VMAT2 is inhibited, excess dopamine and related neurotransmitters spill into pathways that govern perception and thought, generating psychotic symptoms.¹⁰ The paranoia, shadow people, and conviction that someone is watching or following you that meth users describe are not personality quirks. They are symptoms of a brain whose dopamine signaling has gone haywire.

Tolerance and the Dopamine Trap

With repeated use, the brain tries to compensate for the dopamine flood by reducing the number of dopamine receptors, particularly a subtype called D2 receptors. Research comparing people with methamphetamine addiction to healthy controls has found significantly lower D2 receptor levels in the addicted group, along with weakened connectivity between brain regions involved in decision-making and emotional regulation.¹¹

This receptor downregulation is what drives tolerance: you need more of the drug to feel the same effect, because the brain has literally removed some of the hardware that responds to dopamine. But it also drives a deeper problem. When the drug is not present, the person’s baseline dopamine signaling is now impaired. Normal pleasures feel muted or absent. Motivation drops. This anhedonia, the inability to feel pleasure from everyday life, is one of the main reasons quitting methamphetamine is so difficult and relapse rates are so high. The brain does recover D2 receptors over months of abstinence, but it is a slow process that leaves a long window of vulnerability.

Injection-Specific Risks

Many of the most dangerous consequences of shooting up meth are not about the drug itself but about the act of injecting. Missing a vein is common, especially as veins collapse after repeated use, and it leads to skin and soft tissue infections, cellulitis, and abscesses. Lifetime rates of these infections among people who inject drugs range widely but have been reported as high as 69%.¹² Many people who inject drugs treat these abscesses themselves rather than seeking medical care, which raises the risk of complications.

Shared needles and non-sterile injection equipment also create a direct route for bloodborne infections. Infective endocarditis, an infection of the heart valves, is markedly increasing among people who inject drugs in the United States and Canada, and long-term outcomes are poor.¹³ HIV and syphilis transmission are also elevated. Among men who have sex with men, methamphetamine injection has been associated with a roughly 50% higher likelihood of being HIV-positive compared to injecting other drugs, an association that appears to be driven primarily by higher rates of condomless sex rather than needle sharing itself.¹⁴ Meth powerfully lowers sexual inhibition and increases impulsive risk-taking, which turns the drug into an indirect driver of sexually transmitted infections.

Beyond the Brain and Heart

Methamphetamine affects the immune system broadly. Animal studies show the drug alters how immune cells multiply and which chemical signals they produce across multiple tissues, weakening the body’s ability to fight off pathogens.¹⁵ This helps explain why people who use meth seem to get sicker faster and more severely from infections compared to the general population.

The kidneys are another casualty. Methamphetamine-induced hyperthermia, where body temperature spikes dangerously during use, can trigger a chain of events including muscle breakdown (rhabdomyolysis), which dumps cellular debris into the bloodstream and overwhelms the kidneys. Acute kidney injury from meth intoxication has been linked to this hyperthermia as well as direct vascular damage within the kidneys themselves.¹⁶

The lungs face their own distinct threat. Research has established a definite association between methamphetamine use and pulmonary arterial hypertension, a serious condition where the blood vessels in the lungs become progressively blocked. Some individuals appear to be genetically more vulnerable to this vascular damage, carrying gene variants that impair their ability to detoxify the drug.¹⁷ Pulmonary arterial hypertension progresses to right-sided heart failure if untreated, and there is no simple fix once it takes hold.

“Meth Mouth” and Oral Destruction

The dramatic dental decay associated with methamphetamine use, often called “meth mouth,” is one of the drug’s most visible physical markers. The mechanism involves several factors working together. Methamphetamine reduces saliva production by activating receptors in the sympathetic nervous system that suppress salivary glands. The drug and its byproducts also lower the pH of whatever saliva remains, creating an acidic environment that erodes tooth enamel.¹⁸

On top of the chemical assault, behavioral factors pile on. People using meth tend to consume large amounts of sugary drinks, grind their teeth compulsively, and neglect basic oral hygiene. The dry, acidic mouth becomes an ideal breeding ground for decay-causing bacteria. The combination of reduced saliva, acid exposure, sugar consumption, teeth grinding, and neglected brushing produces the severe, rapid tooth destruction that gives the condition its name.¹⁹

The Fentanyl Contamination Problem

A danger that has emerged more recently is fentanyl showing up in methamphetamine supplies. Drug-checking services have found fentanyl in about 9% of methamphetamine samples submitted for testing, with substantial geographic variation across the United States.²⁰ Among people who use meth and were tested for drug metabolites, a wide range of fentanyl-related compounds showed up, including potent analogues like carfentanil, and about 11% tested positive for fentanyl despite reporting no intentional opioid use in the past month.²¹

This is a particularly lethal combination for someone injecting meth. A stimulant user who has no opioid tolerance can be killed by a tiny amount of fentanyl. Many people who use meth are aware of this risk. In qualitative research, users described various strategies to reduce their exposure to contaminated supplies, but these strategies were inconsistent and depended heavily on the social context and the source of the drugs.²² The practical advice from harm-reduction organizations is straightforward: use fentanyl test strips on every batch, never use alone, and keep naloxone nearby even if you do not consider yourself an opioid user.

Pregnancy and Fetal Effects

Methamphetamine crosses the placenta. Animal research using self-administered meth at moderate doses during pregnancy found that exposed offspring were significantly delayed in reaching all assessed developmental milestones compared to controls, even though their birth weights were not obviously different.²³ The finding that developmental harm occurred even without growth restriction suggests that the drug’s neurotoxic effects on the developing brain do not require extreme doses. Human studies in this area are limited by ethical constraints, but the animal data is consistent with clinical reports of developmental and behavioral problems in children exposed to methamphetamine in utero.

What Treatment Looks Like

There is no FDA-approved medication for methamphetamine use disorder as of this writing, which makes treatment fundamentally different from opioid addiction, where drugs like buprenorphine and methadone are available. The most evidence-backed behavioral approach is contingency management, a system where people earn tangible rewards for submitting drug-free urine samples. It has been called the most effective intervention currently available for stimulant use disorder.²⁴ In randomized trials, people receiving contingency management in addition to standard treatment achieved longer periods of abstinence than those receiving standard treatment alone.²⁵

Pilot programs have also explored using contingency management not just for abstinence from meth but simultaneously for adherence to HIV prevention medication among men who have sex with men. In one study, participants who received incentives for taking pre-exposure prophylaxis (PrEP) showed high medication adherence, while those in the meth-abstinence arm had more drug-free samples. Both goals appeared achievable within the same program framework, pointing toward a model where harm reduction and drug treatment are not treated as competing priorities.²⁶

For someone who is injecting meth and not ready to stop, harm reduction still matters. Syringe service programs, fentanyl test strips, and access to naloxone address the most immediately life-threatening risks. The gap between “still using” and “getting help” does not have to be empty, and the research increasingly supports meeting people where they are rather than requiring abstinence as the price of entry to care.